Gene Therapy For Parkinson's Disease: Strategies And Operational Requirements

Gene therapy holds great promise as a potential treatment for Parkinson’s disease, a disorder for which currently available medications do not causally treat the underlying disease mechanisms. However, given the early stage of gene therapy research in this therapeutic area, questions abound regarding its utility and practicality in treating Parkinson’s disease. Those questions have important implications for gene therapy clinical programs, underscoring the importance of early engagement with regulators, payers, and the Parkinson’s patient community. Download the available white paper to find out more.